Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
540 W Pueblo St
Santa Barbara, CA 93105Phone+1 805-898-3270Fax+1 805-898-3405
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2003 - 2004- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2002 - 2003
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2001 - 2002
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1998 - 2001
University of Zambia, School of MedClass of 1994
Certifications & Licensure
CA State Medical License 2000 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread Start of enrollment: 2014 Jun 10
Publications & Presentations
PubMed
- 7 citationsT cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer.Manish A Shah, Takashi Kojima, Daniel Hochhauser, Peter Enzinger, Judith Raimbourg
Future Oncology. 2022-07-19 - 46 citationsSafety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.Nicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, Edward Arrowsmith, Todd M Bauer
Clinical Genitourinary Cancer. 2020-12-01 - 343 citationsEfficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 ...Manish A. Shah, Takashi Kojima, Daniel Hochhauser, Peter C. Enzinger, Judith Raimbourg
JAMA Oncology. 2019-04-01
Press Mentions
Sansum Medical Group Santa Barbara Introduces Board of DirectorsSeptember 12th, 2024- Colorectal Cancer Awareness MonthMarch 11th, 2023
Copper Nanoparticles: Green Synthesis and Managing Fruit Rot Disease of Chilli Caused by Colletotrichum CapsiciDecember 8th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
